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A B S T R A C T   
Lipid droplets are cellular organelles used for lipid storage with a hydrophobic core of neutral lipids enclosed by 
a phospholipid monolayer. Besides presenting as giant single organelles in fat tissue, lipid droplets are also 
widely present as a multitude of small structures in hepatocytes, where they play key roles in health and disease 
of the liver. In addition to lipid storage, lipid droplets are also directly involved in lipid metabolism, membrane 
biosynthesis, cell signaling, inflammation, pathogen-host interaction and cancer development. In addition, they 
interact with other cellular organelles to regulate cellular biology. It is fair to say that the exact functions of lipid 
droplets in cellular physiology remain largely obscure. Thus prompted, here we aim to analyze the corpus of 
contemporary biomedical literature to create a framework as to how the role of lipid droplets in hepatocyte 
physiology and pathophysiology should be understood. The resulting framework should help understanding the 
interaction of lipid droplets with other organelles in important liver diseases, including fatty liver disease, viral 
hepatitis and liver cancer and direct further research directions.   
1. Introduction 
Lipid droplets (LDs) are specialized cellular organelles that are pre-
sent in many types of cells and tissues mediating lipid storage (Murphy, 
2001). Although diverse in morphology, LDs are universally character-
ized by the presence of a hydrophobic core that mainly consists of tri-
acylglycerols and sterol esters and other neutral lipids, encapsulated by 
a phospholipid monolayer that contains integral and peripheral proteins 
(Fig. 1). Initially, LD function was thought to be limited as a passive 
reservoir for lipid storage, but an increasing body of research shows that 
the surface proteome of LDs allows them to actively participate in a 
variety of cell biological functions (Fig. 1). Accordingly, LDs are now 
recognized as dynamic hubs in lipid metabolism, energy homeostasis 
and cellular signaling (Sanjabi et al., 2015). Although much of the 
mechanistic details remain largely obscure, it is evident that many of 
these functions are exerted through interactions of LDs with other or-
ganelles (Guo et al., 2009). 
Because of drastic changes in life style and environment, obesity has 
grown into a global pandemic during the past decades. The increase in 
obesity is accompanied by a plethora of comorbidities, in particular 
insulin resistance, type 2 diabetes mellitus, hypertension, cardiovascular 
disease and dyslipidemia. Thus, research on LDs mainly focused on fat 
cells of the adipose tissue, which is the largest energy reservoir of the 
body. It is important to note, however, that the liver controls lipid 
metabolism in the body, and lipid metabolism dysfunction is universally 
associated with hepatic physiopathology (Gluchowski et al., 2017). 
Liver cells contain many LDs, and LDs in these cells are subject to 
interaction with other cellular organelles including endoplasmic retic-
ulum (ER), mitochondria, peroxisomes and lysosomes (Olzmann and 
Carvalho, 2019). In this review, we aim to analyze the role of LDs in 
hepatocyte physiopathology, focusing on their multifaceted interactions 
with other cellular organelles in the context of the most important liver 
diseases. 
2. The interactions between lipid droplets and other organelles 
The notion that LDs may have a more profound action in cellular 
physiology apart from their role as a lipid reservoir comes from the 
realization that LDs directly interact with other cellular organelles. In 
turn, this insight was driven by the development of novel imaging 
technologies that allow direct visualization of the physical interactions 
between LDs with other organelles in living cells (Fig. 2). A variety of 
interactions have now been described, in particular between LDs and 
ER, mitochondria, peroxisomes or lysosomes, respectively. As it will 
become clear below, LD-ER and LD-mitochondrion interactions play the 
most prominent roles in development and progression of liver diseases. 
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2.1. LD-ER interaction 
The ER is responsible for LD generation. Neutral lipids, which form 
the core of LDs, are synthesized in the ER and are subsequently packed in 
a phospholipid monolayer after which the nascent organelles may bud 
from the ER into the cytosol in a multistep process (Tauchi-Sato et al., 
2002). Depending on the exact phospholipid composition and resulting 
surface tension, LDs of different sizes are formed, while final release 
from the ER requires surface protein loading of the LDs (Chorlay et al., 
2019). Protein translocation from the ER membrane to LDs requires such 
proteins to have a hydrophobic hairpin structure. Importantly, however, 
LDs often do not dissociate at all but remain associated to the ER. Indeed, 
in yeast LDs universally appear connected to the ER membrane (Jac-
quier et al., 2011). Using spectral imaging of monkey COS-7 cells, 85 % 
of LDs were estimated to be in physical contact with the ER (Valm et al., 
2017). Such association may facilitate recycling of LD components. If 
cellular metabolic need requires lipid mobilization, the level of neutral 
lipids presents in LDs will decline. Some integral droplet proteins such as 
AAM-B and UBXD8 will then return back to the ER (Zehmer et al., 2009), 
while other proteins are transported to the Golgi complex (Olofsson 
et al., 2009). Yet other LD proteins are degraded via 
ubiquitin-proteasome system or autophagy (Bersuker and Olzmann, 
2017). Seipin is stably associated with nascent ER-LD contacts (Salo 
et al., 2016), which supports the formation of ER-LD contacts and pro-
motes delivery of triacylglycerols from ER to LDs (Salo et al., 2019). 
Thus overall, LDs appear to be dynamic structures and their constituents 
can enter a multitude of other subcellular compartments. 
The ER is very sensitive to changes in the intracellular environment, 
if such changes provoke accumulation of unfolded or misfolded proteins 
in ER and unfolded protein response (UPR) ensues. The presence of a 
UPR is implicated in many diseases (Tschurtschenthaler et al., 2017) 
involving a highly ordered signal transduction cascade that includes 
IRE1, PERK and ATF6, and results in either a return to ER homeostasis or 
induction of programmed cell death (Walter and Ron, 2011). An 
evolutionary conserved effect of the UPR is the induction of LD forma-
tion (Fei et al., 2009; Rutkowski et al., 2008). This may be a consequence 
of metabolic reprogramming following activation of the UPR, which 
involves downregulation of many metabolism-related genes including 
transcription factors and thus promotes lipid accumulation in the liver 
(Oyadomari et al., 2008; Rutkowski et al., 2008). In turn, LDs can take 
up unfolded and misfolded proteins from the ER and hence alleviate ER 
stress (Ploegh, 2007). Thus, LDs actively contribute to appropriate 
functioning of the ER. 
2.2. LD-mitochondrion interaction 
Besides the ER, mitochondrion is also a prime target for interaction 
with LDs (Wang et al., 2013). In mammalian cells, lipolysis of 
LD-derived fatty acids takes place in mitochondrion through β-oxidation 
(Shaw et al., 2008; Tarnopolsky et al., 2007). During nutrient starvation, 
LD-derived lipids are necessary for ATP production and accordingly 
LD-mitochondrion interactions are induced in an AMPK 
activation-dependent process (Herms et al., 2015). Direct connections 
between LDs and mitochondria are required to enable flux of fatty acids 
into mitochondria (Rambold et al., 2015). 
Based on LD-interaction status, mitochondria can be divided into two 
subpopulations, peridroplet mitochondria that binds to LDs and cyto-
plasmic mitochondria, with distinct role in lipid metabolism (Benador 
et al., 2019). Peridroplet mitochondria have a distinctive protein 
composition and structure reflecting their role in lipid metabolism, 
supporting both triacylglycerol synthesis and β-oxidation (Benador 
et al., 2018). Important in LD-mitochondrion interaction is the perilipin 
protein family. They act as surface scaffolds and regulators in LDs (Wang 
and Sztalryd, 2011). The members of perilipin family interact with 
Fig. 1. The structure and biogenesis of lipid droplets. Lipid droplet (LD) has a hydrophobic core with neutral lipids, consisting of triacylglycerols (TAGs) and sterol 
esters, encircled by a phospholipid monolayer with integral and peripheral proteins. The classical hypothesis of LD biogenesis is based on ER-budding model. TAGs 
and sterol esters are synthesized in the ER. With increasing neutral lipid accumulation, lens will grow and bud into a nearly spherical droplet from ER membrane. 
Subsequently, proteins from ER bilayer and cytosol translocate to LD surface. Through new fatty acids synthesis and LD fusion or coalescence, LDs will grow into 
different sizes. 
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mitochondrion to exert functions in lipid metabolism. In mammals, this 
function is mediated by Perilipin 5 (Plin5) which recruits mitochondria 
to the LD surface through its C-terminal region but concomitantly pro-
tects the mitochondrion from excessive fatty acid exposure by regulating 
LD hydrolysis and controlling local fatty acid flux (Wang et al., 2011). In 
addition to lipid metabolism regulation and lipotoxicy defense, Plin5 
also has antioxidant role to alleviate oxidative damage, whereas 
oxidative stress is intimately associated with mitochondrial electron 
transport chain (Zhu et al., 2020). 
Some aspects of LD-mitochondrion interactions also involve ER. 
Calcium (Ca+) is an important intracellular second messengers stored in 
the ER (Van Den Brink et al., 1999). In mammalian models, LDs mediate 
Ca+ signal transduction from the ER to the mitochondrion (Bush et al., 
1992; Greineisen et al., 2014). Another example is MIGA2, an outer 
mitochondrial membrane protein that links mitochondria to LDs, but 
also binds to the membrane proteins VAP-A or VAP-B of ER. Through 
multifaceted links among mitochondria, ER and LDs, MIGA2 promotes 
de novo lipogenesis from non-lipid precursors and stores lipids in LDs 
(Freyre et al., 2019). Hence, LDs are an essential component in the joint 
regulation of cellular metabolism by the ER and the mitochondrial 
compartment. 
2.3. LD-peroxisome interaction 
Peroxisomes are membrane-bound organelles present in the cyto-
plasm of all eukaryotic cells. They are essential in metabolism of lipids 
and reactive oxygen species. In the liver, peroxisomes also catabolize 
bile acid intermediates. Both LDs and peroxisomes are formed in the ER. 
This is thought to occur at the same ER subdomains where the reticulon 
homology domain of the multiple C2 domain containing transmembrane 
protein is located. This suggests that an intimate interactions between 
LDs and peroxisomes may exist, as both organelles are generated at the 
same location and both have an important role in cellular lipid meta-
bolism (Joshi et al., 2018). An obvious example of LD-peroxisome 
interaction functionality is the β-oxidation of fatty acids. This crosstalk 
links lipolysis mediated by LDs to catabolize fatty acid β-oxidation 
within the peroxisomes (Shai et al., 2016), which likely involves 
trafficking of proteins and lipids between these organelles and the 
mitochondrion (Joshi and Cohen, 2019). Experimental demonstration of 
the interactions between LDs, peroxisomes and mitochondria and its 
role in regulation of energy consumption has been reported in murine 
adipocytes involving the CIDE-ATGL-PPARα pathway (Zhou et al., 
2018). Thus a picture emerges that around the LD a metabolic niche is 
generated that coordinates cellular lipid metabolism. 
2.4. LD-lysosome interaction 
Lysosomes are important for cellular waste disposal and accordingly 
contain a variety of enzymes that enable the digestion of biomolecules 
including lipids. Lysosomes are closely linked to LD catabolism. 
Although LD catabolism is most directly linked to lipolysis, LDs can also 
be subject to autophagy. Conversely, degradation of cellular compo-
nents by lysosomes may increase availability of triacylglycerol and thus 
necessitate LD formation (Singh et al., 2009). In the liver, involvement 
of autophagy in lipid catabolism is most prominent during fasting or 
nutrient deprivation, although lipophagy also maintains constitutive 
lipid degradation. Lysosomes regulate lipid metabolism through auto-
phagy, and inhibiting autophagy can increase the amount of tri-
acylglycerols and LDs (Singh et al., 2009). LDs provide lipid precursors 
for autophagosome biogenesis, more specifically for autophagosomal 
membrane formation (Settembre and Ballabio, 2014). Furthermore, the 
ER can also contribute to the interactions between LD and autophagy 
(Velázquez et al., 2016). 
3. Lipid droplets and their interactions with other organelles in 
major liver diseases 
Dysregulation and imbalance of lipid metabolism in the liver inevi-
tably cause pathogenesis. The most prominent disorder in this respect is 
fatty liver disease. Fatty liver disease is a leading etiology of primary 
liver cancer, and altered hepatic lipid metabolism can fuel hepatic 
carcinogenesis providing a direct link between LDs and liver cancer 
(Fig. 3). In addition, intracellular pathogens, including hepatitis viruses, 
can exploit LDs to sustain their life cycle. Lipid metabolism is a 
Fig. 2. Interactions between lipid 
droplets and other cellular organelles. 
ER is the place to form LDs, and LD-ER 
contacts transport lipids and proteins. 
Mitochondria can be divided into two 
subpopulations: peridroplet mitochon-
dria that bind to LDs support tri-
acylglycerol synthesis and conversely 
reduce β-oxidation activity, and cyto-
plasmic mitochondria that take place 
lipolysis to supply energy. Peroxisomes 
exert lipolysis through catabolization of 
fatty acid β-oxidation. Lysosomes 
degrade fatty acids through autophagy. 
ER: endoplasmic reticulum; LDs: lipid 
droplets.   
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complicated process involving many different organelles to maintain the 
balance. Imbalance of lipid homeostasis will cause damage to organelles 
and promote disease progression. 
3.1. Metabolic dysfunction-associated fatty liver disease 
Metabolic dysfunction-associated fatty liver disease (MAFLD) is 
under the new nomenclature for pathology previously referred as non- 
alcoholic fatty liver disease (NAFLD). MAFLD is defined as hepatic 
steatosis in conjunction with at least one of three conditions, including 
overweight/obesity, presence of type 2 diabetes mellitus, or evidence of 
metabolic dysregulation (Eslam et al., 2020). Although the precise 
epidemiology of MAFLD remains unknown as a new terminology, the 
prevalence of NAFLD has been estimated to be 25 % of the global pop-
ulation (Younossi et al., 2016). 
Steatosis may present as either microvesicular or macrovesicular LDs 
in hepatocytes and is the hallmark of fatty liver disease. Fatty acids in 
the liver are derived from diet uptake, de novo lipogenesis and endog-
enous lipid catabolism. Imbalance in lipid anabolism and catabolism 
causes excessive fatty acid storage in hepatocytes as LDs, promoting the 
development of fatty liver disease. Fatty acids can also be converted to 
lipid intermediates that impair insulin signaling, referring as lipid- 
induced insulin resistance and lipotoxicity. Accumulated LDs will 
trigger further hepatic oxidative stress and inflammation, resulting in 
continued liver damage and more advanced disease stage such as stea-
tohepatitis (Chen et al., 2019). 
Disease progression of MAFLD involves the interactions between LDs 
and other organelles. Hepatic steatosis progresses to steatohepatitis 
often accompanied by ER stress, and mitochondrial and lysosomal 
dysfunctions. Activation of cell stress pathways and impairment of 
organelle functions play important role. Disorder of lipid metabolism 
causes chronic ER stress in the liver via disruption of calcium homeo-
stasis, and ER stress in turn induces LD formation and hepatic steatosis 
(Fu et al., 2011; Yamamoto et al., 2010). PLIN2 is a LD-associated 
protein that provides reciprocal stabilization to LDs, and its expression 
is positively correlated to mitochondrial activation (Xu et al., 2019). 
LD-associated proteins are also important for MAFLD progression. 
The PAT family proteins located on LD surface include perilipin, adi-
pophilin, TIP47, S3-12 and OXPAT. They are differentially expressed in 
fatty compared to normal liver. Perilipin, adipophilin and TIP47 are 
associated with different LD sizes. TIP47 affects nascent LDs, while 
perilipin and adipophilin are important for maturation and maintenance 
of LDs in human hepatocytes (Straub et al., 2008). CIDEA and Fsp27 are 
LD-associated proteins that promote LD fusion and regulate lipid stor-
age. Their expression is dramatically upregulated in hepatic steatosis 
(Zhou et al., 2012). This process may be mediated by MKP5. Because loss 
of MKP5 in mice activates p38, resulting in increased expression of 
CIDEA and Fsp27 (Tang et al., 2019). 17β-hydroxysteroid 
dehydrogenase-13 (17β-HSD13), a newly identified LD-associated pro-
tein, has been demonstrated as a pathogenic protein in MAFLD. 
17β-HSD13 controls the number and size of LDs and is causative for fatty 
liver phenotype (Su et al., 2014). High expression of 17β-HSD13 in fatty 
liver has been shown to be induced by liver X receptor α through 
SREBP-1c in mouse model (Su et al., 2017). 
3.2. Alcoholic liver disease 
Alcoholic liver disease (ALD) is one type of epidemic chronic fatty 
liver disease worldwide. Accumulation of LDs is a common feature in 
both MAFLD and ALD, but chronic alcohol consumption results in some 
unique characteristics of ALD. 
Alcohol intake can induce LD accumulation and alter LD properties 
to induce macrosteatosis (Orlicky et al., 2011; Valcin et al., 2020). 
Except direct effects on LD accumulation, alcohol and its metabolite, 
acetaldehyde, indirectly induce LD generation through damage of other 
organelles. They can decrease mitochondrial β-oxidation, impair lyso-
some biogenesis and increase cholesterol level by inducing ER stress that 
leads to mitochondrial impairment (Chao et al., 2018; Farfán Labonne 
et al., 2009; Lluis et al., 2003). LD motility maintaining the interactions 
with other organelles relies on cytoskeletal motors (Kilwein and Welte, 
2019). Alcohol induces microtubule acetylation, which impairs LD 
motility and accumulation of large, immobile LDs in the liver (Groebner 
et al., 2019). Thus, alcohol-induced lipid deposition decreases LD 
motility and prevents active communications with other organelles. 
Fig. 3. Lipid droplets in major liver 
diseases. Excessive fatty acids lead to 
lipid metabolic disorder. Imbalance of 
lipid homeostasis will trigger LD for-
mation that promotes devolopment of 
metabolic dysfunction-associated fatty 
liver disease. Similarly, hepatitis virus 
infections, especially HBV and HCV, 
accelerate lipid accumulation and cause 
inflammation in the liver. In turn, LDs 
support the life cycle of hepatitis vi-
ruses. Fatty acids sustain HCC cell 
growth and create a supportive micro-
environment for cancer stem cells. LDs: 
lipid droplets; HBV: hepatitis B virus; 
HCV: hepatitis C virus; HCC: hepato-
cellular carcinoma.   
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3.3. Viral hepatitis 
Viral hepatitis can be caused by the five hepatotropic viruses 
including hepatitis A, B, C, D and E. Globally, about 500 million people 
are chronically infected with hepatitis B (HBV) or C (HCV) virus. The 
link of HBV to LDs is mainly through the viral HBx protein, which causes 
lipid accumulation by upregulation of the liver X receptor and its lipo-
genic target genes (Kim et al., 2007; Na et al., 2009). HBV viral particle 
production has been shown to impair LD expansion associated with in-
hibition of the expression of CIDE proteins in cell culture models. 
Because CIDE proteins support HBV production; this may serve as 
negative feedback loop for maintaining persistent infection (Yasumoto 
et al., 2017). 
HCV is the best known pathogen with close connections to LDs. LDs 
serve as putative sites for viral assembly during HCV replication 
(Miyanari et al., 2007). The process of infectious HCV particle assembly 
consists of nucleocapsid formation, budding into the ER, and virion 
maturation. The capsid Core protein closely associates with LDs, and 
further recruits nonstructural proteins around LDs to participate in virus 
production (Miyanari et al., 2007). HCV assembly likely takes place at 
the sites requiring interactions of ER and LDs (Filipe and McLauchlan, 
2015). A recent high-resolution imaging study in cell culture models 
indicates selective recruitment of ER membranes wrapping LDs to form 
membranous structure coupling HCV replication and assembly (Lee 
et al., 2019). HCV infection also causes ER stress and leads to Ca2+
release from ER to mitochondria resulting in mitochondrial dysfunction. 
This triggers oxidative stress, lipogenesis and decreased oxidative 
phosphorylation (Scrima et al., 2018). HCV Core protein can also be 
efficiently targeted to LDs outside the context of virion assembly, and 
induce LD redistribution and hepatic steatosis (Boulant et al., 2008; 
Camus et al., 2014). This partially explains why MAFLD is a prominent 
feature of chronic hepatitis C patients, and eradication of HCV by anti-
viral treatment dramatically decreases liver steatosis (Tada et al., 2018). 
3.4. Liver cancer 
Fatty liver disease and viral hepatitis are the leading etiologies of 
primary liver cancer, namely hepatocellular carcinoma (HCC). 
Enhanced lipogenesis is a metabolic hallmark of cancer cells, and 
aberrant lipid metabolism universally occurs in HCC cells (Hu et al., 
2020). Fat-containing liver lesions are commonly seen in HCC patients 
(Balci et al., 2009). In HCC, lipogenesis pathway is over-activated, while 
fatty acid oxidation is concomitantly downregulated (Björnson et al., 
2015; Yamashita et al., 2009). Specific to the high rate of tumor growth, 
HCC cells require fatty acids to support their proliferation (Menendez 
and Lupu, 2007). Hypoxia is a common feature in liver cancer devel-
opment. Hypoxia inhibits mitochondrial activity and ROS accumulation 
through HIF/HEY1/PINK1 pathway (Kung-Chun Chiu et al., 2019). 
Under hypoxic conditions, LD catabolism is inhibited by ATGL, the rate 
limiting lipase in lipolysis, leading to LD accumulation, and thus 
adapting cellular metabolism and provoking resistance to programmed 
cell death (Munir et al., 2019; Zhang et al., 2017). 
Recent evidence indicates the essential involvement of lipid meta-
bolism in cancer stem cells (CSCs). Activation of intrinsic lipid pathways 
in CSCs upregulates fatty acid de novo synthesis (Yasumoto et al., 2016). 
Furthermore, the lipid context in tumor microenvironment, in particular 
the stem cell niche, regulates CSC behavior (Nieman et al., 2011). Liver 
tumors are known to harbor CSCs (Cao et al., 2020), and the role of LDs 
and lipid metabolism in this unique cancer cell population deserves to be 
further studied. 
4. Conclusion 
The liver is a central organ in lipid metabolism and LDs are widely 
present in hepatocytes. LDs play key roles in health and diseases of the 
liver, involving in lipid metabolism, energy homeostasis, cell signaling, 
inflammation, pathogen-host interaction and carcinogenesis. LDs are 
highly dynamic organelles closely associated and interacting with other 
cellular organelles. The presence of LDs and their interactions with 
different organelles has been widely observed in different liver diseases. 
However, there remain many knowledge gaps in understanding the 
implications of these interactions. The exact biological functions of 
different interactions between LDs and specific organelles are still 
largely elusive. The mechanisms that regulate these dynamic in-
teractions have hardly been revealed. Thus, mechanistically deciphering 
the role of LDs and their interactions with other organelles in the liver 
shall help to better understand the pathogenesis of major liver diseases 
including MAFLD, viral hepatitis and cancer, as well as to facilitate 
therapeutic development. 
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Vidal, A., Ferguson, C., Rentero, C., Tebar, F., Enrich, C., Parton, R.G., Gross, S.P., 
Pol, A., 2015. AMPK activation promotes lipid droplet dispersion on detyrosinated 
microtubules to increase mitochondrial fatty acid oxidation. Nat. Commun. 6, 7176. 
Hu, B., Lin, J.Z., Yang, X.B., Sang, X.T., 2020. Aberrant lipid metabolism in 
hepatocellular carcinoma cells as well as immune microenvironment: a review. Cell 
Prolif. 53 (3), e12772. 
Jacquier, N., Choudhary, V., Mari, M., Toulmay, A., Reggiori, F., Schneiter, R., 2011. 
Lipid droplets are functionally connected to the endoplasmic reticulum in 
&em&Saccharomyces cerevisiae&/em&gt. J. Cell. Sci. 124 (14), 2424. 
Joshi, A.S., Cohen, S., 2019. Lipid Droplet and Peroxisome Biogenesis: Do They Go Hand- 
in-Hand? Front. Cell Dev. Biol. 7, 92. 
Joshi, A.S., Nebenfuehr, B., Choudhary, V., Satpute-Krishnan, P., Levine, T.P., 
Golden, A., Prinz, W.A., 2018. Lipid droplet and peroxisome biogenesis occur at the 
same ER subdomains. Nat. Commun. 9 (1), 2940. 
Kilwein, M.D., Welte, M.A., 2019. Lipid Droplet Motility and Organelle Contacts. Contact 
2, 2515256419895688. 
Kim, K.H., Shin, H.J., Kim, K., Choi, H.M., Rhee, S.H., Moon, H.B., Kim, H.H., Yang, U.S., 
Yu, D.Y., Cheong, J., 2007. Hepatitis B virus X protein induces hepatic steatosis via 
transcriptional activation of SREBP1 and PPARgamma. Gastroenterology 132 (5), 
1955–1967. 
Kung-Chun Chiu, D., Pui-Wah Tse, A., Law, C.-T., Ming-Jing Xu, I., Lee, D., Chen, M., Kit- 
Ho Lai, R., Wai-Hin Yuen, V., Wing-Sum Cheu, J., Wai-Hung Ho, D., Wong, C.-M., 
Zhang, H., Oi-Lin Ng, I., Chak-Lui Wong, C., 2019. Hypoxia regulates the 
mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 
pathway. Cell Death Dis. 10 (12), 934. 
Lee, J.Y., Cortese, M., Haselmann, U., Tabata, K., Romero-Brey, I., Funaya, C., 
Schieber, N.L., Qiang, Y., Bartenschlager, M., Kallis, S., Ritter, C., Rohr, K., 
Schwab, Y., Ruggieri, A., Bartenschlager, R., 2019. Spatiotemporal coupling of the 
hepatitis C virus replication cycle by creating a lipid droplet- proximal membranous 
replication compartment. Cell Rep. 27 (12), 3602–3617 e3605.  
Lluis, J.M., Colell, A., García–Ruiz, C., Kaplowitz, N., Fernández–Checa, J.C., 2003. 
Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through 
endoplasmic reticulum stress. Gastroenterology 124 (3), 708–724. 
Menendez, J.A., Lupu, R., 2007. Fatty acid synthase and the lipogenic phenotype in 
cancer pathogenesis. Nat. Rev. Cancer 7 (10), 763–777. 
Miyanari, Y., Atsuzawa, K., Usuda, N., Watashi, K., Hishiki, T., Zayas, M., 
Bartenschlager, R., Wakita, T., Hijikata, M., Shimotohno, K., 2007. The lipid droplet 
is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9 (9), 
1089–1097. 
Munir, R., Lisec, J., Swinnen, J.V., Zaidi, N., 2019. Lipid metabolism in cancer cells 
under metabolic stress. Br. J. Cancer 120 (12), 1090–1098. 
Murphy, D.J., 2001. The biogenesis and functions of lipid bodies in animals, plants and 
microorganisms. Prog. Lipid Res. 40 (5), 325–438. 
Na, T.Y., Shin, Y.K., Roh, K.J., Kang, S.A., Hong, I., Oh, S.J., Seong, J.K., Park, C.K., 
Choi, Y.L., Lee, M.O., 2009. Liver X receptor mediates hepatitis B virus X protein- 
induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma. 
Hepatology 49 (4), 1122–1131. 
Nieman, K.M., Kenny, H.A., Penicka, C.V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. 
R., Romero, I.L., Carey, M.S., Mills, G.B., Hotamisligil, G.S., Yamada, S.D., Peter, M. 
E., Gwin, K., Lengyel, E., 2011. Adipocytes promote ovarian cancer metastasis and 
provide energy for rapid tumor growth. Nat. Med. 17 (11), 1498–1503. 
Olofsson, S.-O., Boström, P., Andersson, L., Rutberg, M., Perman, J., Borén, J., 2009. 
Lipid droplets as dynamic organelles connecting storage and efflux of lipids. 
Biochimica et Biophysica Acta (BBA) – Mol. Cell Biol. Lipids 1791 (6), 448–458. 
Olzmann, J.A., Carvalho, P., 2019. Dynamics and functions of lipid droplets. Nat. Rev. 
Mol. Cell Biol. 20 (3), 137–155. 
Orlicky, D.J., Roede, J.R., Bales, E., Greenwood, C., Greenberg, A., Petersen, D., 
McManaman, J.L., 2011. Chronic ethanol consumption in mice alters hepatocyte 
lipid droplet properties. Alcohol. Clin. Exp. Res. 35 (6), 1020–1033. 
Oyadomari, S., Harding, H.P., Zhang, Y., Oyadomari, M., Ron, D., 2008. 
Dephosphorylation of translation initiation factor 2α enhances glucose tolerance and 
attenuates hepatosteatosis in mice. Cell Metab. 7 (6), 520–532. 
Ploegh, H.L., 2007. A lipid-based model for the creation of an escape hatch from the 
endoplasmic reticulum. Nature 448 (7152), 435–438. 
Rambold, Angelika S., Cohen, S., Lippincott-Schwartz, J., 2015. Fatty acid trafficking in 
starved cells: regulation by lipid droplet lipolysis, autophagy, and mitochondrial 
fusion dynamics. Dev. Cell 32 (6), 678–692. 
Rutkowski, D.T., Wu, J., Back, S.-H., Callaghan, M.U., Ferris, S.P., Iqbal, J., Clark, R., 
Miao, H., Hassler, J.R., Fornek, J., Katze, M.G., Hussain, M.M., Song, B., 
Swathirajan, J., Wang, J., Yau, G.D.Y., Kaufman, R.J., 2008. UPR Pathways Combine 
to Prevent Hepatic Steatosis Caused by ER Stress-Mediated Suppression of 
Transcriptional Master Regulators. Dev. Cell 15 (6), 829–840. 
Salo, V.T., Belevich, I., Li, S., Karhinen, L., Vihinen, H., Vigouroux, C., Magré, J., 
Thiele, C., Hölttä-Vuori, M., Jokitalo, E., Ikonen, E., 2016. Seipin regulates ER-lipid 
droplet contacts and cargo delivery. EMBO J. 35 (24), 2699–2716. 
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